Logo

Vysis Announces That Habschmidt Is New CFO

Dec 21, 1998
Premium

DOWNERS GROVE, Ill.--Vysis, a genomic diagnostics company here, has named James Habschmidt as its chief financial officer. Habschmidt was formerly executive vice-president of business development and finance and chief financial officer of Rand McNally.

Among its other products, Vysis offers a line of genetic imaging workstations. Habschmidt "will play an active role in corporate developments as Vysis continues to expand its market presence," predicted John Bishop, Vysis's president and CEO.

Filed under

Informatics
Breaking News
The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.